ALXN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Alexion Pharmaceuticals Inc's account receivable for the three months ended in Sep. 2014 was $436 Mil. Alexion Pharmaceuticals Inc's revenue for the three months ended in Sep. 2014 was $555 Mil. Hence, Alexion Pharmaceuticals Inc's days sales outstanding for the three months ended in Sep. 2014 was 71.74.
Alexion Pharmaceuticals Inc's days sales outstanding declined from Sep. 2013 (92.29) to Sep. 2014 (71.74).
Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Account receivable can be measured by Days Sales Outstanding.
Alexion Pharmaceuticals Inc's Days Sales Outstanding for the fiscal year that ended in Dec. 2013 is calculated as
Alexion Pharmaceuticals Inc's Days Sales Outstanding for the quarter that ended in Sep. 2014 is calculated as:
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Alexion Pharmaceuticals Inc Annual Data
Alexion Pharmaceuticals Inc Quarterly Data